BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 19701111)

  • 1. Carcinoma NOS is a common histologic diagnosis and is increasing in proportion among non-small cell lung cancer histologies.
    Ou SH; Zell JA
    J Thorac Oncol; 2009 Oct; 4(10):1202-11. PubMed ID: 19701111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
    Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
    J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary signet-ring carcinoma (SRC) of the lung: a population-based epidemiologic study of 262 cases with comparison to adenocarcinoma of the lung.
    Ou SH; Ziogas A; Zell JA
    J Thorac Oncol; 2010 Apr; 5(4):420-7. PubMed ID: 20130484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.
    Morgensztern D; Waqar S; Subramanian J; Trinkaus K; Govindan R
    J Thorac Oncol; 2012 Oct; 7(10):1485-9. PubMed ID: 22982649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.
    Loo PS; Thomas SC; Nicolson MC; Fyfe MN; Kerr KM
    J Thorac Oncol; 2010 Apr; 5(4):442-7. PubMed ID: 20195168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
    Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
    J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidental Diagnosis of Asymptomatic Non-Small-Cell Lung Cancer: A Registry-Based Analysis.
    Kocher F; Lunger F; Seeber A; Amann A; Pircher A; Hilbe W; Fiegl M
    Clin Lung Cancer; 2016 Jan; 17(1):62-7.e1. PubMed ID: 26420370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of the number of lymph nodes removed at lobectomy in stage IA non-small cell lung cancer.
    Ou SH; Zell JA
    J Thorac Oncol; 2008 Aug; 3(8):880-6. PubMed ID: 18670306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender, histology, and time of diagnosis are important factors for prognosis: analysis of 1499 never-smokers with advanced non-small cell lung cancer in Japan.
    Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Kawahara M; Maruyama Y
    J Thorac Oncol; 2010 Jul; 5(7):1011-7. PubMed ID: 20502360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis.
    Subramanian J; Morgensztern D; Goodgame B; Baggstrom MQ; Gao F; Piccirillo J; Govindan R
    J Thorac Oncol; 2010 Jan; 5(1):23-8. PubMed ID: 19934774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.
    Lara MS; Brunson A; Wun T; Tomlinson B; Qi L; Cress R; Gandara DR; Kelly K
    Lung Cancer; 2014 Aug; 85(2):264-9. PubMed ID: 24878033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor?
    Hsu LH; Chu NM; Liu CC; Tsai SY; You DL; Ko JS; Lu MC; Feng AC
    Lung Cancer; 2009 Nov; 66(2):262-7. PubMed ID: 19299032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of fine needle aspiration cytology in the pathological typing of non-small cell lung cancer.
    Nizzoli R; Tiseo M; Gelsomino F; Bartolotti M; Majori M; Ferrari L; De Filippo M; Rindi G; Silini EM; Guazzi A; Ardizzoni A
    J Thorac Oncol; 2011 Mar; 6(3):489-93. PubMed ID: 21258246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing age and carcinoma not otherwise specified: a 20-year population study of 40,118 lung cancer patients.
    Sagerup CM; Småstuen M; Johannesen TB; Helland A; Brustugun OT
    J Thorac Oncol; 2012 Jan; 7(1):57-63. PubMed ID: 21900838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.
    Morgensztern D; Waqar S; Subramanian J; Gao F; Trinkaus K; Govindan R
    J Thorac Oncol; 2012 Oct; 7(10):1479-84. PubMed ID: 22982648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid on-site evaluation has high diagnostic yield differentiating adenocarcinoma vs squamous cell carcinoma of non-small cell lung carcinoma, not otherwise specified subgroup.
    Celik B; Khoor A; Bulut T; Nassar A
    Pathol Oncol Res; 2015 Jan; 21(1):167-72. PubMed ID: 24889857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of the non-size-based AJCC T2 descriptors: visceral pleura invasion, hilar atelectasis, or obstructive pneumonitis in stage IB non-small cell lung cancer is dependent on tumor size.
    Ou SH; Zell JA; Ziogas A; Anton-Culver H
    Chest; 2008 Mar; 133(3):662-9. PubMed ID: 17925418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma.
    Chen KY; Chang CH; Yu CJ; Kuo SH; Yang PC
    Cancer; 2005 Jun; 103(12):2566-74. PubMed ID: 15852359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification.
    Lee HJ; Choe G; Jheon S; Sung SW; Lee CT; Chung JH
    J Thorac Oncol; 2010 May; 5(5):649-57. PubMed ID: 20354454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status.
    Ou SH; Zell JA; Ziogas A; Anton-Culver H
    Cancer; 2008 May; 112(9):2011-20. PubMed ID: 18361399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.